Easton Reaches $400k for Purchase Orders

Pharmaceutical Investing

Easton Pharmaceuticals got an approximate $400,000 total in purchase orders for the quarter from its sub-distributors for the Mexican market.

Easton Pharmaceuticals (OTC:EAPH) got an approximate $400,000 total in purchase orders for the quarter from its sub-distributors for the Mexican market.
As quoted in the press release:

The purchase orders include a new order received just last week, including an upfront cash deposit which has brought the total for all Easton / BMV’s woman’s diagnostic and treatment products to approximately $400,000 USD in purchases for the quarter since its first “Gynofit” launch in April of this year.
The PO’s include a new product where a new sub-distribution agreement has recently been executed. Complete details to follow on a subsequent press release once legally approved by all parties. A third product launch agreement is nearing completion with a major international pharmaceutical company as a JV partner which includes royalty and upfront payments on closing. Complete details are forthcoming.
The $400,000 USD in purchase orders for the quarter represents a good start on product launches. New products launches in the pharmaceutical industry typically start slow and take several years for marketing efforts to gain awareness and traction. Sales of its woman’s diagnostics and treatment products will continue to grow which will soon include a third product in its portfolio for Mexico and Latin America. These revenues coincide with sales of its recent acquisition of iBliss Vapor where minor changes to its agreement were recently executed. Updated news on iBliss and the expected closing of Alliance soon to follow.

Click here to read the full press release.

Source: www.marketwired.com

The Conversation (0)
×